Risk factors for cholangiocarcinoma
- PMID: 17625428
- DOI: 10.1097/MEG.0b013e328224b935
Risk factors for cholangiocarcinoma
Abstract
Cholangiocarcinoma occurs with a varying frequency in different areas of the world. Some of the variations in incidence rates can be explained by the distribution of risk factors in different geographic regions and ethnic groups. Several accepted risk factors for cholangiocarcinoma include infestation with liver flukes, primary sclerosing cholangitis, hepatolithiasis, choledochal cysts, cirrhosis, and infusion of certain chemical agents. Approximately, 90% of patients diagnosed with cholangiocarcinoma do not have a recognized risk factor for the malignancy. The study by Ahrens et al. [16] finds that obesity and gallstones are risk factors for developing extrahepatic cholangiocarcinoma in men patients. Obesity was found to have a 'dose-effect' relationship with the strength of statistical association. No significant association was reported for tobacco or alcohol use, hepatitis, cirrhosis, diabetes, or inflammatory bowel disease. Although the author's definition of extrahepatic cholangiocarcinoma was unusual, the association of obesity with the risk of developing cholangiocarcinoma persisted for all anatomic subsites.
Comment on
-
Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study.Eur J Gastroenterol Hepatol. 2007 Aug;19(8):623-30. doi: 10.1097/01.meg.0000243876.79325.a1. Eur J Gastroenterol Hepatol. 2007. PMID: 17625430
Similar articles
-
The epidemiology of cholangiocarcinoma.Semin Liver Dis. 2004 May;24(2):115-25. doi: 10.1055/s-2004-828889. Semin Liver Dis. 2004. PMID: 15192785 Review.
-
Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.Cancer Epidemiol Biomarkers Prev. 1993 Nov-Dec;2(6):537-44. Cancer Epidemiol Biomarkers Prev. 1993. PMID: 8268770 Review.
-
[Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].Harefuah. 2003 Jun;142(6):421-5, 486. Harefuah. 2003. PMID: 12858825 Hebrew.
-
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.Am J Gastroenterol. 2007 May;102(5):1016-21. doi: 10.1111/j.1572-0241.2007.01104.x. Epub 2007 Feb 23. Am J Gastroenterol. 2007. PMID: 17324130
-
Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.Hepatology. 2000 Jan;31(1):7-11. doi: 10.1002/hep.510310103. Hepatology. 2000. PMID: 10613720
Cited by
-
NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells.Life Sci. 2020 Dec 1;262:118548. doi: 10.1016/j.lfs.2020.118548. Epub 2020 Oct 7. Life Sci. 2020. PMID: 33038372 Free PMC article.
-
Preneoplastic conditions underlying bile duct cancer.Langenbecks Arch Surg. 2012 Aug;397(6):861-7. doi: 10.1007/s00423-012-0943-7. Epub 2012 Mar 6. Langenbecks Arch Surg. 2012. PMID: 22391777 Free PMC article. Review.
-
Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients.World J Surg. 2015 Jun;39(6):1537-42. doi: 10.1007/s00268-015-2965-0. World J Surg. 2015. PMID: 25648078
-
Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma.World J Gastroenterol. 2008 Dec 14;14(46):7033-58. doi: 10.3748/wjg.14.7033. World J Gastroenterol. 2008. PMID: 19084911 Free PMC article. Review.
-
Body Mass Index Can Increase the Risk of Gallbladder Cancer: A Meta-Analysis of 14 Cohort Studies.Med Sci Monit Basic Res. 2016 Nov 30;22:146-155. doi: 10.12659/msmbr.901651. Med Sci Monit Basic Res. 2016. PMID: 27899789 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical